AbbVie Inc.: retained earnings or deficit
Retained earnings or deficit for AbbVie Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All AbbVie Inc. financial histories
What this measure means
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
Exact concept: us-gaap:RetainedEarningsAccumulatedDeficit. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2013-12-31 to 2025-12-31. The SEC response was captured on 2026-09-20.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2025-12-31 | -15,493,000,000 | USD | 2026-02-20 | 10-K · 0001551152-26-000008 |
| At date | 2024-12-31 | -7,900,000,000 | USD | 2026-02-20 | 10-K · 0001551152-26-000008 |
| At date | 2023-12-31 | -1,000,000,000 | USD | 2025-02-14 | 10-K · 0001551152-25-000020 |
| At date | 2022-12-31 | 4,784,000,000 | USD | 2024-02-20 | 10-K · 0001551152-24-000011 |
| At date | 2021-12-31 | 3,127,000,000 | USD | 2023-02-17 | 10-K · 0001551152-23-000011 |
| At date | 2020-12-31 | 1,055,000,000 | USD | 2022-02-18 | 10-K · 0001551152-22-000007 |
| At date | 2019-12-31 | 4,717,000,000 | USD | 2021-02-19 | 10-K · 0001551152-21-000008 |
| At date | 2018-12-31 | 3,368,000,000 | USD | 2020-02-21 | 10-K · 0001551152-20-000007 |
| At date | 2017-12-31 | 5,459,000,000 | USD | 2019-02-27 | 10-K · 0001551152-19-000008 |
| At date | 2016-12-31 | 4,378,000,000 | USD | 2018-02-16 | 10-K · 0001551152-18-000014 |
| At date | 2015-12-31 | 2,248,000,000 | USD | 2017-02-17 | 10-K · 0001551152-17-000004 |
| At date | 2014-12-31 | 535,000,000 | USD | 2016-02-19 | 10-K · 0001047469-16-010239 |
| At date | 2013-12-31 | 1,567,000,000 | USD | 2015-02-20 | 10-K · 0001047469-15-000995 |
Related financial histories
- AbbVie Inc.: total assets
- AbbVie Inc.: stockholders equity
- AbbVie Inc.: cash and cash equivalents
- AbbVie Inc.: net income or loss
- AbbVie Inc.: operating cash flow
- AbbVie Inc.: capital expenditure payments
- AbbVie Inc.: revenue
- AbbVie Inc.: contract revenue excluding tax
- AbbVie Inc.: financing cash flow
- AbbVie Inc.: investing cash flow
- AbbVie Inc.: basic weighted-average shares
- AbbVie Inc.: diluted weighted-average shares
- AbbVie Inc.: basic earnings per share
- AbbVie Inc.: diluted earnings per share
- AbbVie Inc.: income tax expense or benefit
- AbbVie Inc.: net property, plant and equipment
- AbbVie Inc.: share-based compensation expense
- AbbVie Inc.: operating income or loss
- AbbVie Inc.: current assets
- AbbVie Inc.: interest expense
- AbbVie Inc.: current liabilities
- AbbVie Inc.: current accounts payable
- AbbVie Inc.: goodwill carrying amount
- AbbVie Inc.: net finite-lived intangible assets
- AbbVie Inc.: net current accounts receivable
- AbbVie Inc.: common-stock repurchase payments
- AbbVie Inc.: net inventory
- AbbVie Inc.: selling, general and administrative expense
Inspect the source
- Entity
- AbbVie Inc. / CIK 0001551152
- Captured
- 2026-09-20T09:18:39.120Z
- SEC response SHA-256
1fa00a2de3a0434fb2ebba8b1678cc379b16dc435a4f3e5c696efb7f9029698a
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001551152.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))